UNC1215, also known as UNC-1215 CAS: 1415800-43-9, is a small molecule inhibitor that has shown promise in the treatment of various cancers. This product is primarily known for its ability to inhibit the bromodomain containing protein 4 (BRD4), which plays a key role in tumorigenesis and inflammation. In this article, we will explore the chemical properties of UNC1215, its potential health benefits, safety considerations, and dosing information.
The chemical name for UNC1215 is 2-(3-(4-chlorophenyl)-2-propenoyl)-1H-indole-5-carboxylic acid.
The molecular formula of UNC1215 is C18H12ClNO3.
The molecular weight of UNC1215 is 329.74 g/mol.
The CAS number for UNC1215 is 1415800-43-9.
Top ten keywords from Google and Synonyms Synonym:
- BRD4 inhibitors
- Cancer treatment
- Targeted therapy
- Drug resistance
Health benefits of this product:
UNC1215 has been found to have a variety of potential health benefits. One of the most studied applications of this compound is in the treatment of cancer. Specifically, UNC1215 may be effective in treating leukemia, lymphoma, and other tumors. Studies have shown that UNC1215 can inhibit BRD4 enzymes, leading to decreased tumor growth and potentially improved survival rates.
In addition to cancer treatment, UNC1215 may also have potential in the treatment of other conditions related to inflammation and epigenetics. These conditions include cardiovascular disease and autoimmune disorders.
UNC1215 works by inhibiting the activity of BRD4 enzymes. BRD4 enzymes play a critical role in regulating gene transcription and chromatin remodeling. By inhibiting these enzymes, UNC1215 may be able to influence these processes and potentially affect the development and progression of various diseases.
The precise mechanism of action of UNC1215 is not well understood, but it is believed to work by binding to and inhibiting the activity of BRD4 enzymes.
UNC1215 is generally considered to be safe when used as directed. However, as with any medication or supplement, there is some risk of side effects. It is important to consult with a healthcare provider before using UNC1215, especially if you have any underlying medical conditions or are taking other medications.
Some potential side effects of UNC1215 include nausea, vomiting, fatigue, and diarrhea. More serious side effects may include liver toxicity and blood disorders. If you experience any of these symptoms or other severe side effects, you should seek medical attention immediately.
The optimal dosage of UNC1215 will depend on the specific application and the individual's needs. It is important to follow the dosing instructions provided by a healthcare provider or on the product label. In general, doses of UNC1215 in the range of 30-60 mg/kg per day have been used in animal studies.
UNC1215 is a promising compound with potential health benefits in the treatment of cancer and other diseases related to inflammation and epigenetics. Its mechanism of action through the inhibition of BRD4 enzymes is a promising avenue for new drug therapies. While generally safe, it is important to consult with a healthcare provider before using UNC1215 and to follow dosing instructions carefully. Further research is needed to fully understand the potential benefits and risks of this compound